BIO
Price
$243.97
Change
+$0.51 (+0.21%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
9.79B
27 days until earnings call
ELMD
Price
$21.97
Change
+$0.30 (+1.38%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
139.58M
67 days until earnings call
Interact to see
Advertisement

BIO vs ELMD

Header iconBIO vs ELMD Comparison
Open Charts BIO vs ELMDBanner chart's image
Bio-Rad Laboratories
Price$243.97
Change+$0.51 (+0.21%)
Volume$1.19K
Capitalization9.79B
Electromed
Price$21.97
Change+$0.30 (+1.38%)
Volume$3.36K
Capitalization139.58M
BIO vs ELMD Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. ELMD commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a StrongBuy and ELMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BIO: $243.47 vs. ELMD: $21.67)
Brand notoriety: BIO and ELMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 70% vs. ELMD: 138%
Market capitalization -- BIO: $9.79B vs. ELMD: $139.58M
BIO [@Medical Specialties] is valued at $9.79B. ELMD’s [@Medical Specialties] market capitalization is $139.58M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileELMD’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • ELMD’s FA Score: 0 green, 5 red.
According to our system of comparison, ELMD is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while ELMD’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 4 bearish.
  • ELMD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ELMD is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical Specialties) experienced а +4.94% price change this week, while ELMD (@Medical Specialties) price change was +4.48% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was -0.29%.

Reported Earning Dates

BIO is expected to report earnings on Jul 24, 2025.

ELMD is expected to report earnings on Sep 02, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($9.79B) has a higher market cap than ELMD($140M). ELMD has higher P/E ratio than BIO: ELMD (36.04) vs BIO (3.64). BIO (-25.887) and ELMD (-26.667) have similar YTD gains . ELMD has higher annual earnings (EBITDA): 5.81M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. ELMD (10.4M). ELMD has less debt than BIO: ELMD (1.09M) vs BIO (1.41B). BIO has higher revenues than ELMD: BIO (2.67B) vs ELMD (51.7M).
BIOELMDBIO / ELMD
Capitalization9.79B140M6,996%
EBITDA-654.76M5.81M-11,266%
Gain YTD-25.887-26.66797%
P/E Ratio3.6436.0410%
Revenue2.67B51.7M5,166%
Total Cash1.61B10.4M15,452%
Total Debt1.41B1.09M129,017%
FUNDAMENTALS RATINGS
BIO vs ELMD: Fundamental Ratings
BIO
ELMD
OUTLOOK RATING
1..100
1120
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9552
PRICE GROWTH RATING
1..100
6050
P/E GROWTH RATING
1..100
8464
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIO's Valuation (80) in the Medical Specialties industry is in the same range as ELMD (96). This means that BIO’s stock grew similarly to ELMD’s over the last 12 months.

ELMD's Profit vs Risk Rating (68) in the Medical Specialties industry is in the same range as BIO (100). This means that ELMD’s stock grew similarly to BIO’s over the last 12 months.

ELMD's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for BIO (95). This means that ELMD’s stock grew somewhat faster than BIO’s over the last 12 months.

ELMD's Price Growth Rating (50) in the Medical Specialties industry is in the same range as BIO (60). This means that ELMD’s stock grew similarly to BIO’s over the last 12 months.

ELMD's P/E Growth Rating (64) in the Medical Specialties industry is in the same range as BIO (84). This means that ELMD’s stock grew similarly to BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOELMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 4 days ago
69%
Declines
ODDS (%)
Bearish Trend 26 days ago
66%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRT94.841.13
+1.21%
Federal Realty Investment Trust
CHSCM24.04-0.08
-0.33%
CHS
SDGR20.49-0.07
-0.34%
Schrodinger
MGNX1.27-0.04
-3.05%
MacroGenics
TMC7.18-0.31
-4.14%
TMC the metals company

ELMD and

Correlation & Price change

A.I.dvisor tells us that ELMD and KRMD have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELMD and KRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELMD
1D Price
Change %
ELMD100%
-1.10%
KRMD - ELMD
33%
Poorly correlated
+4.99%
BIO - ELMD
32%
Poorly correlated
+1.03%
NNOX - ELMD
31%
Poorly correlated
+2.48%
BDSX - ELMD
30%
Poorly correlated
+2.52%
RVTY - ELMD
30%
Poorly correlated
+1.12%
More